Literature DB >> 6347477

Four distinct antigen systems on human thymus and T cells defined by monoclonal antibodies: immunohistological and immunochemical studies.

Y Ishii, S Kon, T Takei, J Fujimoto, K Kikuchi.   

Abstract

Human thymus and T cell antigens were identified by using four distinct monoclonal antibodies (MoAb), designated 2D5, 5B3, 7A5 and 9D4. 2D5 antibody reacted with most human thymocytes and a few peripheral lymphocytes as well as with a subpopulation (20%) of bone marrow cells, and precipitated a 45K molecular weight (mol. wt.) component from 125I-labelled thymus cell lysate. 7A5 antibody also reacted with the majority (80%) of thymocytes but neither with peripheral lymphocytes nor with bone marrow cells. The antigen detected by 7A5 was a glycoprotein consisting of 48K and 12K mol. wt. components, which were non-covalently associated with each other. 5B3 reacted with virtually all of human thymus and T cells but not with the majority of B cells and bone marrow cells. This reagent precipitated a 72K mol. wt. glycoprotein from thymus and T cells. An additional 65K mol. wt. glycoprotein was precipitated by 5B3 together with the 72K mol. wt. component, but with poor reproducibility. 9D4 antibody, on the other hand, reacted with a 200K mol. wt. component from thymus and T cells as well as 220K and 210K components from the non-T cell fraction of tonsil lymphocytes. Whereas antigens detected by 2D5 and 7A5 appeared to be highly expressed on cortical thymocytes, the antigen defined by 5B3 occurred much more abundantly on medullary thymocytes and peripheral T cells than on cortical thymocytes. Based on the data described above, it is suggested that 7A5, 5B3 and 9D4 MoAb recognize human homologues of mouse TL, Ly-1 and Ly-5 antigens, respectively, whereas 2D5 antibody seems to resemble OKT10, as described by others.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347477      PMCID: PMC1535537     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Subpopulations of T-lymphocytes. Physical separation, functional specialisation and differentiation pathways of sub-sets of thymocytes and thymus-dependent peripheral lymphocytes.

Authors:  K Shortman; H Von Boehmer; J Lipp; K Hopper
Journal:  Transplant Rev       Date:  1975

2.  Lymphocytes as models for the study of mammalian cellular differentiation.

Authors:  H Cantor; E A Boyse
Journal:  Immunol Rev       Date:  1977-01       Impact factor: 12.988

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Studies on the germinal center. IV. Autoradiographic study of lymph node germinal centers in relation to zonal differentiation.

Authors:  Y Ishii; M Mori; T Onoé
Journal:  J Reticuloendothel Soc       Date:  1972-04

6.  Isolation of glycoproteins from pig lymphocyte plasma membrane using Lens culinaris phytohemagglutinin.

Authors:  M J Hayman; M J Crumpton
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse.

Authors:  H Lemke; G J Hammerling; C Hohmann; K Rajewsky
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

9.  An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci.

Authors:  S E Cullen; B D Schwartz
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

10.  Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200.

Authors:  I S Trowbridge
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  7 in total

1.  The sheep analogue of leucocyte common antigen (LCA).

Authors:  J F Maddox; C R Mackay; M R Brandon
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

2.  Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies.

Authors:  Y Kokai; Y Ishii; K Kikuchi
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.

Authors:  Y Ishii; T Takami; H Yuasa; T Takei; K Kikuchi
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells.

Authors:  N Kiyokawa; Y Kokai; K Ishimoto; H Fujita; J Fujimoto; J I Hata
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  A novel human B-lymphocyte antigen shared with lymphoid dendritic cells: characterization by monoclonal antibody.

Authors:  Y Ishii; T Takami; Y Kokai; H Yuasa; J Fujimoto; T Takei; K Kikuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  The cytotoxic analysis of T cell receptor V delta 1+ T cell lines derived from the synovial fluid of rheumatoid arthritis patients.

Authors:  M Ohta; N Sato
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

7.  Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker.

Authors:  J Fujimoto; J Hata; E Ishii; N Kiyokawa; S Tanaka; Y Morikawa; K Shimizu; H Hajikano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.